No Data
No Data
Express News | Bausch + Lomb : Raymond James Initiates Coverage With Outperform Rating; Price Target $19
RBC Capital Reviews Bausch + Lomb's Q1 Results
Despite Bausch + Lomb reporting Q1/24 results that were ahead of consensus estimates (~3%/~2% ahead on revenue/adj. EBITDA, respectively) and reiterated 2024 guidance (higher organic growth offset by
Toronto Stocks Modestly Higher as Loblaw Shares Gain on 1Q Profit Beat
Toronto stocks were modestly higher on Wednesday. Sector performance was mixed in the session, with the biggest losses logged in the process industry and energy sectors. On the gainers' side, tech, utilities and health tech outperformed.
Needham Says Bausch + Lomb's Q1 Showed a "Strong Start" to The Year
Bausch + Lomb's Q1 2024 revenue and adjusted EBITDA beat consensus and management reiterated its reported financial guidance despite tougher currency. Miebo saw significant sequential growth and will
Bausch & Lomb Corp (BLCO) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Net Loss Widening
Bausch + Lomb Announces First-Quarter 2024 Results